Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05480865
Title SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation (Argonaut)
Acronym Argonaut
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Navire Pharma Inc., a BridgeBio company
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD | ITA | GRC | FRA | ESP | DNK | AUS


No variant requirements are available.